June 16: Our paper on the role of cyclophilin A in HCV replication (which describes a new, potentially broad-spectrum, antiviral mechanism of action of cyclophilin inhibitors) has been published in eLife! Check it out here!
June 2: We have received funding from the NRC to support our collaborative effort to develop a rapid point-of-care diagnostic test for SARS-CoV-2. This is a collaboration between Deep Biologics and Queen’s University team members Drs. Colpitts (DBMS), Crudden (Chemistry), Escobedo (Chemical Engineering), Lohans (DBMS) and Sheth (KGH and Pathology). Check out the CTV interview!
May 25: Dr. Colpitts was interviewed by CBC News about antiviral strategies for COVID-19. Check out the article here.
April 24: Dr. Colpitts was awarded a Banting Discovery Award to evaluate membrane remodelling as an antiviral target for coronaviruses. Thank you, Banting Foundation, for funding this timely research.
April 23: We are happy to have been awarded an NSERC Discovery Grant to support our research for 5 years. Thank you, NSERC!
March 18: Our review on HCV entry has been published! A collaborative effort with our colleague Mirjam Zeisel in France, and input from our very own Celine Tsai! Check it out here.
March 10: Caleb has earned an NSERC Undergraduate Student Research Award to support his summer research project evaluating host-targeting agents as coronavirus antivirals. Congratulations, Caleb!
November 27: Celine has been awarded research funding from the Arts and Science Undergraduate Society at Queen’s University to support her winter term research project. Way to go, Celine!